Published in Science on January 07, 1921
THE AMERICAN CHEMICAL SOCIETY. Science (1921) 2.14
Isolation of bacteriophages from group H streptococci. J Virol (1972) 1.79
Transfection of group H streptococci. J Bacteriol (1973) 1.34
Bacteriphage activity in homogenates of crown gall tissue. J Virol (1968) 1.31
Profiles of grammatical morphology and sentence imitation in children with specific language impairment and Down syndrome. J Speech Lang Hear Res (2002) 1.25
Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet (1990) 1.25
The primary antibacterial defense mechanism of the bladder. Invest Urol (1975) 1.24
Role of surface mucin in primary antibacterial defense of bladder. Urology (1977) 1.19
Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. Int J Urol (2000) 1.17
Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science (1980) 1.15
A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology (1996) 1.13
Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol (1987) 1.12
Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology (1990) 1.12
Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol (1987) 1.11
Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun (1979) 1.09
Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect. Invest Urol (1978) 1.04
Percutaneous nephrostomy: experience in 107 kidneys. Urology (1980) 1.04
Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol (1994) 0.99
Bladder surface mucin. Its antibacterial effect against various bacterial species. Am J Pathol (1978) 0.97
Urinary tract infections in the female patient. Urol Clin North Am (1985) 0.96
Peyronie's disease: surgical experience and presentation of a proximal approach. J Urol (1989) 0.95
Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol (1984) 0.95
Erectile impotence associated with transurethral prostatectomy. Urology (1982) 0.95
Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin. J Urol (1996) 0.95
Role of urothelial surface mucoprotein in intrinsic bladder defense. Urology (1977) 0.94
Subclinical infection of the silicone breast implant surface as a possible cause of capsular contracture. Aesthetic Plast Surg (1992) 0.94
Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanisms. Urol Clin North Am (1986) 0.91
Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation. Urology (1986) 0.90
In vitro adherence of radioactively labeled Escherichia coli in normal and cystitis-prone females. Infect Immun (1979) 0.90
Synchronous ipsilateral renal adenocarcinoma, transitional cell carcinoma of the renal pelvis and metastatic renal lymphoma. J Urol (2000) 0.88
The protective effect of heparin in experimental bladder infection. J Surg Res (1978) 0.88
Elevated urinary norepinephrine in interstitial cystitis. Urology (1999) 0.87
Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infect Immun (1980) 0.87
Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis. Am J Clin Oncol (1990) 0.86
Impairment of antibacterial effect of bladder surface mucin by protamine sulfate. J Infect Dis (1981) 0.84
Protamine sulfate and vancomycin are synergistic against Staphylococcus epidermidis prosthesis infection in vivo. J Urol (1994) 0.83
Characterization of microbial presence at the surface of silicone mammary implants. Ann Plast Surg (1995) 0.83
Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol (1982) 0.83
A new method for cytodestruction of bladder epithelium using protamine sulfate and urea. J Urol (1994) 0.83
Vesical defense: assessment of adsorption potential with live, dead, and metabolically inhibited Escherichia coli and 99mTC-labeled sulfur colloid particles. Surg Forum (1977) 0.83
Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol (1995) 0.83
Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. Urology (1987) 0.82
Activation of urinary kallikrein in patients with interstitial cystitis. J Urol (1994) 0.82
Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide. J Urol (1985) 0.82
Pentosanpolysulfate coating of silicone reduces encrustation. J Endourol (2000) 0.82
Fibroblast behavior in vitro is unaltered by products of staphylococci cultured from silicone implants. Ann Plast Surg (1994) 0.82
Mechanisms of tumor induction in crown gall. I. Production and pathogenicity of spheroplasts of Agrobacterium tumefaciens. Cancer Res (1966) 0.81
Effect of tongue reduction on articulation in children with Down syndrome. Am J Ment Defic (1987) 0.80
The effect of trichomonal vaginitis on vaginal pH. J Urol (1977) 0.80
Electrophysiologic monitoring of the effects of soluble virulence factors produced by Escherichia coli infection in urine. Urology (1996) 0.80
Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol (1983) 0.80
Selective type IV collagen defects in the urothelial basement membrane in interstitial cystitis. J Urol (1995) 0.80
Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology (1997) 0.80
Successful management of radiation cystitis with sodium pentosanpolysulfate. J Urol (1986) 0.80
The intravesical potassium sensitivity test and urodynamics: implications in a large cohort of patients with lower urinary tract symptoms. J Urol (2001) 0.80
Control of recurrent lower urinary tract infection in the postmenopausal woman. J Urol (1982) 0.79
Scrotal actinomycosis. J Urol (1979) 0.78
Urinary tract infections and P blood group antigens. Urology (1984) 0.78
A minimal-world-pair model for teaching the linguistic significance of distinctive feature properties. J Speech Hear Disord (1981) 0.78
Vesical defense: further evidence for a charge-related mucosal anti-adherence mechanism. Surg Forum (1978) 0.78
The production of antibodies to pentosanpolysulfate (ELMIRON, SP-54). J Immunol Methods (1991) 0.78
The effect of testicular torsion on contralateral testis and the production of antisperm antibodies in rabbits. J Urol (1984) 0.78
Urinary glycosaminoglycan excretion as a laboratory marker in the diagnosis of interstitial cystitis. J Urol (1993) 0.78
Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis. J Urol (1994) 0.77
Hemiacidrin irrigation of renal pelvic calculi in patients with ileal conduit urinary diversion. J Urol (1980) 0.77
Group reminiscence therapy and levels of depression in the elderly. Nurse Pract (1986) 0.77
Cryoablation for carcinoma of the prostate. J Surg Oncol (1996) 0.77
New concepts in interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct (1997) 0.77
Prevention of acrolein-induced bladder injury by pentosanpolysulfate. J Urol (1992) 0.76
Elevated stress protein in transitional cells exposed to urine from interstitial cystitis patients. Int J Urol (1998) 0.76
Inactivation of antiadherence effect of bladder surface glycosaminoglycan by a complete urinary carcinogen (N-methyl-N-nitrosourea). J Urol (1983) 0.76
Prophylactic antibiotics in urology. Urol Clin North Am (1987) 0.75
Natural history of interstitial cystitis in 274 patients receiving sulfated polysaccharide therapy. Urology (1999) 0.75
Changing concepts in interstitial cystitis. J Urol (1997) 0.75
Urology-epitomes of progress: detection of nonpalpable varicoceles. West J Med (1981) 0.75
THE AMERICAN CHEMICAL SOCIETY. II. Science (1920) 0.75
THE AMERICAN CHEMICAL SOCIETY SAN FRANCISCO MEETING. Science (1910) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1921) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1921) 0.75
'BERYLLIUM' OR 'GLUCINUM.'. Science (1905) 0.75
THE BUFFALO MEETING OF THE AMERICAN CHEMICAL SOCIETY. IV. Science (1919) 0.75
THE AMERICAN CHEMICAL SOCIETY. IX. Science (1920) 0.75
OUR RADIUM RESOURCES. Science (1913) 0.75
THE WASHINGTON MEETING OF THE AMERICAN CHEMICAL SOCIETY. Science (1912) 0.75
THE AMERICAN CHEMICAL SOCIETY VII. Science (1920) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1913) 0.75
WINTER MEETING OF THE AMERICAN CHEMICAL SOCIETY. Science (1909) 0.75
THE AMERICAN CHEMICAL SOCIETY DETROIT MEETING. Science (1909) 0.75
THE AMERICAN CHEMICAL SOCIETY. VII. Science (1920) 0.75
THE FORTIETH GENERAL MEETING OF THE AMERICAN CHEMICAL SOCIETY. Science (1909) 0.75
THE BUFFALO MEETING OF THE AMERICAN CHEMICAL SOCIETY. III. Science (1919) 0.75
THE AMERICAN CHEMICAL SOCIETY-VI. Science (1919) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1914) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1921) 0.75
THE AMERICAN CHEMICAL SOCIETY. VI. Science (1920) 0.75
THE AMERICAN CHEMICAL SOCIETY. Science (1919) 0.75
SAN FRANCISCO MEETING OF THE AMERICAN CHEMICAL SOCIETY. Science (1910) 0.75
THE AMERICAN CHEMICAL SOCIETY. II. Science (1914) 0.75
PHILADELPHIA MEETING OF THE AMERICAN CHEMICAL SOCIETY. Science (1919) 0.75
THE AMERICAN CHEMICAL SOCIETY. VIII. Science (1920) 0.75